Literature DB >> 16670764

Bypassing complement: evolutionary lessons and future implications.

John P Atkinson1, Michael M Frank.   

Abstract

Lectins like mannan-binding protein are part of the innate immune system. They circulate in association with serine proteases. Upon binding oligosaccharides, they activate the complement cascade analogous to the more familiar but evolutionarily more recent classical pathway, which is triggered by antibody binding to antigen. In this issue of the JCI, Selander et al. developed a sensitive and specific ELISA employing Salmonella-specific sugars to assess the activity of the lectin pathway of complement activation (see the related article beginning on page 1425). This more physiologic assay system allowed the investigators to rigorously define the requirements for lectin pathway activation. Furthermore, they uncovered an unsuspected means for this pathway to reach the desired critical step of activation of the opsonin C3. These types of functional assays will eventually replace the more laborious, less physiologic, and less informative approaches currently in use to monitor complement activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670764      PMCID: PMC1451225          DOI: 10.1172/JCI28622

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  The mechanism of activation of the alternative pathway of complement by cell-bound C4b.

Authors:  T C Farries; K L Steuer; J P Atkinson
Journal:  Mol Immunol       Date:  1990-11       Impact factor: 4.407

2.  Possible C1q bypass loop activation in the haemolytic uraemic syndrome.

Authors:  L Nolin; S O'Regan; M Pelletier; G E Rivard; J G Mongeau; P Robitaille
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

3.  Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.

Authors:  J E May; M M Frank
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

4.  Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.

Authors:  M A Seelen; A Roos; J Wieslander; T E Mollnes; A G Sjöholm; R Wurzner; M Loos; F Tedesco; R B Sim; P Garred; E Alexopoulos; M W Turner; M R Daha
Journal:  J Immunol Methods       Date:  2004-12-15       Impact factor: 2.303

5.  Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.

Authors:  K L Knutzen Steuer; L B Sloan; T J Oglesby; T C Farries; M W Nickells; P Densen; J B Harley; J P Atkinson
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

6.  IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.

Authors:  E Wagner; J L Platt; D N Howell; H C Marsh; M M Frank
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

7.  Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2.

Authors:  Barbro Selander; Ulla Mårtensson; Andrej Weintraub; Eva Holmström; Misao Matsushita; Steffen Thiel; Jens C Jensenius; Lennart Truedsson; Anders G Sjöholm
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms.

Authors:  K H Traustadóttir; B O Rafnar; K Steinsson; H Valdimarsson; K Erlendsson
Journal:  Arthritis Rheum       Date:  1998-03

9.  Alternative complement pathway activation by C4b deposited during classical pathway activation.

Authors:  M Matsushita; H Okada
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

10.  Mechanism of killing of Giardia lamblia trophozoites by complement.

Authors:  M Deguchi; F D Gillin; I Gigli
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more
  15 in total

1.  Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo.

Authors:  Sergey S Seregin; Yasser A Aldhamen; Daniel M Appledorn; Zachary C Hartman; Nathaniel J Schuldt; Jeannine Scott; Sarah Godbehere; Haixiang Jiang; Michael M Frank; Andrea Amalfitano
Journal:  Blood       Date:  2010-05-28       Impact factor: 22.113

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

Review 4.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 5.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

6.  Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.

Authors:  Serena Giuntini; Donald C Reason; Dan M Granoff
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

7.  Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.

Authors:  Sergey S Seregin; Zachary C Hartman; Daniel M Appledorn; Sarah Godbehere; Haixiang Jiang; Michael M Frank; Andrea Amalfitano
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

Review 8.  Evolution of the complement system: from defense of the single cell to guardian of the intravascular space.

Authors:  Michelle Elvington; M Kathryn Liszewski; John P Atkinson
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 9.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.

Authors:  Amelia Clark; Alexander Weymann; Eric Hartman; Yumirle Turmelle; Michael Carroll; Joshua M Thurman; V Michael Holers; Dennis E Hourcade; David A Rudnick
Journal:  Mol Immunol       Date:  2008-05-01       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.